IM Cannabis Reports 2025 Results: Revenue of C$54.7 Million with Over 134% Growth in Germany and Positive Operating Cash Flow

显示全文

该功能仅适用于授权用户

• 债券全称
  IM Cannabis Corp
• 注册地国家
  Canada
• 行业
  Pharmaceutical Preparation and Biotechnology
• М/S&P/F
  *** / *** / ***